Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers

Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes

(2012) Jan J. Molenaar et al.   NATURE

Autosomal dominant polycystic kidney disease: Genetics, mutations and microRNAs

(2011) Ying-Cai Tan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma

(2011) Helena Carén et al.   BMC CANCER

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)

(2011) G Schleiermacher et al.   BRITISH JOURNAL OF CANCER

miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples

(2011) K. De Preter et al.   CLINICAL CANCER RESEARCH

miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA

(2011) Thomas B Hansen et al.   EMBO JOURNAL

Neuroblastoma epigenetics: From candidate gene approaches to genome-wide screenings

(2011) Anneleen Decock et al.   Epigenetics

RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma

(2011) K. A. Cole et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Progress in treatment and risk stratification of neuroblastoma: Impact on future clinical and basic research

(2011) Ingrid Øra et al.   SEMINARS IN CANCER BIOLOGY

A robust method for estimating gene expression states using Affymetrix microarray probe level data

(2010) Megu Ohtaki et al.   BMC BIOINFORMATICS

Introduction into the analysis of high-throughput-sequencing based epigenome data

(2010) M. Huss   BRIEFINGS IN BIOINFORMATICS

Serial Transcriptome Analysis and Cross-Species Integration IdentifiesCentromere-Associated Protein Eas a Novel Neuroblastoma Target

(2010) Naomi J. Balamuth et al.   CANCER RESEARCH

Accurate prediction of neuroblastoma outcome based on miRNA expression profiles

(2010) Johannes H. Schulte et al.   INTERNATIONAL JOURNAL OF CANCER

Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients

(2010) E. Grau et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Integrative genomics identifies LMO1 as a neuroblastoma oncogene

(2010) Kai Wang et al.   NATURE

Epigenetic modifications and human disease

(2010) Anna Portela et al.   NATURE BIOTECHNOLOGY

Differential expression analysis for sequence count data

(2010) Simon Anders et al.   GENOME BIOLOGY

ShortRead: a bioconductor package for input, quality assessment and exploration of high-throughput sequence data

(2009) M. Morgan et al.   BIOINFORMATICS

rtracklayer: an R package for interfacing with genome browsers

(2009) M. Lawrence et al.   BIOINFORMATICS

RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker

(2009) A Misawa et al.   BRITISH JOURNAL OF CANCER

Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients

(2009) Barbara Banelli et al.   INTERNATIONAL JOURNAL OF CANCER

Cholinergic switch associated with morphological differentiation in neuroblastoma

(2009) Franck Bourdeaut et al.   JOURNAL OF PATHOLOGY

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

(2009) Joëlle Vermeulen et al.   LANCET ONCOLOGY

Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array

(2009) Arata Kamimatsuse et al.   PEDIATRIC BLOOD & CANCER

Global MYCN Transcription Factor Binding Analysis in Neuroblastoma Reveals Association with Distinct E-Box Motifs and Regions of DNA Hypermethylation

(2009) Derek M. Murphy et al.   PLoS One

A novel and universal method for microRNA RT-qPCR data normalization

(2009) Pieter Mestdagh et al.   GENOME BIOLOGY

Discovery of DNA methylation markers in cervical cancer using relaxation ranking

(2008) Maté Ongenaert et al.   BMC Medical Genomics

Aberrant methylation of candidate tumor suppressor genes in neuroblastoma

(2008) Jasmien Hoebeeck et al.   CANCER LETTERS

Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome

(2008) M. O. Hoque et al.   CANCER RESEARCH

Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma

(2008) S. Yagyu et al.   CLINICAL CANCER RESEARCH

The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

(2008) Susan L. Cohn et al.   JOURNAL OF CLINICAL ONCOLOGY

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

(2008) Isabelle Janoueix-Lerosey et al.   NATURE

RTPrimerDB: the portal for real-time PCR primers and probes

(2008) S. Lefever et al.   NUCLEIC ACIDS RESEARCH

MYCN regulates oncogenic MicroRNAs in neuroblastoma

(2007) Johannes H. Schulte et al.   INTERNATIONAL JOURNAL OF CANCER

Methylation of tumor-suppressor genes in neuroblastoma: The RASSF1A gene is almost always methylated in primary tumors

(2007) Mariana Bohns Michalowski et al.   PEDIATRIC BLOOD & CANCER